Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

mTOR T572-p , T574-p
Regulatory protein:
PRP4 S402-p , T406-p , S626-p , S628-p
TBK1 S769-p
Treatment:
angiotensin-(1-7) S450-p , S653-p , S696-p , S738-p , S740-p
BI_4834 S626-p
dasatinib S207-p , S211-p , S260-p , S402-p , T406-p , S452-p , S549-p , S551-p , S560-p , S562-p , T572-p , T574-p , T581-p , S583-p , S605-p , S607-p , T614-p , S616-p , S628-p , S694-p , S696-p , S769-p , S781-p , S791-p , T793-p , S795-p , S797-p , S802-p
EGF S260-p , S393-p , S607-p , S616-p , S638-p , S738-p , S740-p , S769-p , S775-p
ischemia S754-p , S756-p
isoproterenol T872-p , S874-p
LRRK2-IN-1 T220-p , S260-p , S389-p , S391-p , S402-p , T406-p , S560-p , S562-p , T614-p , S616-p , S713-p
MEK_inhibitor_I S414-p
metastatic potential T411-p , S450-p , S696-p , S769-p , S775-p
MG132 K54-ub
nocodazole S177-p , S179-p , S181-p , S186-p , S187-p , S207-p , S209-p , S211-p , T220-p , S227-p , S234-p , S260-p , S304-p , S306-p , S308-p , S389-p , S391-p , S393-p , S402-p , T406-p , T416-p , S429-p , S431-p , S436-p , S450-p , S452-p , S465-p , S478-p , S560-p , S562-p , T572-p , T574-p , T581-p , S583-p , S590-p , S592-p , Y604-p , S605-p , S607-p , S626-p , S628-p , T649-p , S667-p , S683-p , S685-p , S713-p , S715-p , S717-p , S725-p , T727-p , S752-p , S754-p , S756-p , S769-p , S781-p
quinalizarin S391-p , S393-p , T445-p , S465-p , T614-p , S616-p
SB202190 S429-p , S431-p
SII_angiotensin_2 S738-p , S797-p
Torin1 T572-p , T574-p
UV S769-p , S773-p , S775-p
vemurafenib S752-p , S754-p , S756-p